Skip to content
GenoLensGenoLens

SERPING1

Chr 11q12.1

serpin family G member 1

Aliases:
C1IN, C1-INH, HAE1, HAE2, C1INH
MANE:
ENST00000278407.9

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • COVID-19 research

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Hereditary angioedema types I and II

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Primary immunodeficiency or monogenic inflammatory bowel disease

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • hereditary angioedema with C1Inh deficiency

    0.83
  • hereditary angioedema type 1

    0.75
  • hereditary angioedema

    0.73
  • angioedema

    0.62
  • hereditary angioedema type 2

    0.61
  • C1 inhibitor deficiency

    0.61
  • hereditary disease

    0.53
  • Bartholin gland disease

    0.50
  • asthma

    0.48
  • complement deficiency

    0.46

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Plasma protease C1 inhibitor

Serine protease inhibitor, which acrs as a regulator of the classical complement pathway (PubMed:10946292, PubMed:11527969, PubMed:3458172, PubMed:6416294). Forms a proteolytically inactive stoichiometric complex with the C1r or C1s proteases (PubMed:10946292, PubMed:3458172, PubMed:6416294). May also regulate blood coagulation, fibrinolysis and the generation of kinins (PubMed:8495195). Very efficient inhibitor of FXIIa. Inhibits chymotrypsin and kallikrein (PubMed:8495195)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.